Collegium Pharmaceutical, Inc.
(NASDAQ : COLL)

( )
COLL After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
0.54%18.491.8%$136.66m
ICPTIntercept Pharmaceuticals, Inc.
0.77%91.2318.6%$96.63m
SAGESAGE Therapeutics, Inc.
-1.51%164.468.8%$79.59m
JAZZJazz Pharmaceuticals Plc
-0.28%129.422.3%$71.74m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.74%161.036.3%$58.17m
PRGOPerrigo Co. Plc
-0.75%49.196.8%$54.20m
ZGNXZogenix, Inc.
1.79%38.069.9%$47.79m
UTHRUnited Therapeutics Corporation
-0.78%103.5014.3%$44.63m
CTLTCatalent Inc
-0.02%44.442.4%$40.01m
HZNPHorizon Pharma plc
-0.48%25.146.7%$34.23m
PTLAPortola Pharmaceuticals, Inc.
1.02%35.767.6%$33.53m
ICLRICON Plc
-0.28%134.674.1%$31.06m
ZYNEZynerba Pharmaceuticals Inc
1.11%10.018.3%$29.64m
MYOKMyoKardia, Inc.
-2.81%47.692.1%$25.34m
MNKMallinckrodt Plc
-0.87%18.2021.0%$24.91m

Company Profile

Collegium Pharmaceutical, Inc. operates as a pharmaceutical company, which engages in the developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR. The Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy. The Nucynta is a release formulation of tapentadol indicated for the management of acute pain severe enough to require an opioid analgesic. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Stoughton, MA.